Onconic Therapeutics: "Zaqbo oral disintegrating tablet confirmed to show drug exposure equivalent to existing tablet"
Predicted impact: Low
Routine shareholders' meeting notice and proxy documents; procedural only.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.